NanoVibronix regains Nasdaq compliance by meeting $2.5M equity minimum

ENvue Medical, Inc.

Received Nasdaq confirmation on Nov 20, 2023 that it meets minimum stockholders' equity of $2.5M.
Previously disclosed deficiency on May 23, 2023 with equity of ~$2.2M; now resolved.
Listing matter closed; no further action required per Nasdaq Staff.

item 8.01 item 9.01

ENvue Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-042203

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.